# Arrivo BioVentures

**Canonical:** https://apis.io/providers/arrivo-bioventures/  
**Website:** https://arrivobio.com  
**APIs profiled:** 0

Arrivo BioVentures is a biopharmaceutical holding company developing first‑of‑its‑kind medicines for hard‑to‑treat diseases. It focuses on targeting the root cause of conditions such as major depressive disorder and severe acute pancreatitis, aiming for meaningful outcomes that extend patients’ lives. The company partners with institutions like the Mayo Clinic and Daiichi Sankyo and is backed by investors including Jazz Pharmaceuticals and Orlando Health Ventures.

## Kin Score — 5.3 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 5.3).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 9.5 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Arrivo Bioventures Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biopharma, Drug Development, Clinical Trials, Partnerships

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/arrivo-bioventures/). Scores are computed from the provider's own public artifacts under a published rubric.